Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon

ClinicalTrials.gov ID: NCT02683408

Public ClinicalTrials.gov record NCT02683408. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Diosmiplex is a product marketed for the management of diseases due to venous and microvascular dysfunction. Raynaud's phenomenon is a disorder of characterized by spasm of small arteries and impaired microvascular flow. This study will examine the effects of diosmiplex on the frequency and severity of Raynaud's episodes in susceptible people.

Study identification

NCT ID
NCT02683408
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Primus Pharmaceuticals
Industry
Enrollment
87 participants

Conditions and interventions

Interventions

Other · Dietary Supplement

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2016 (Actual)
Primary completion
Jul 2017 (Actual)
Completion
Jul 2017 (Actual)
Last update posted
Aug 17, 2017

2016 – 2017

United States locations

U.S. sites
11
U.S. states
8
U.S. cities
11
Facility City State ZIP Site status
Sun Valley Arthritis Center Peoria Arizona 85381 —
Advanced Arthritis Care and Research Scottsdale Arizona 85258 —
Valerius Medical Group Los Alamitos California 90720 —
Science and Research Institute, Inc. Jupiter Florida 33458 —
Jeffrey Alper, MD Naples Florida 34102 —
Steven Kimmel MD Tamarac Florida 33321 —
Diagnostic Rheumatology Indianapolis Indiana 46227 —
Arthritis Treatment Center Frederick Maryland 21702 —
Henry Ford Hospital Detroit Michigan 48202 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
West Virginai Research Institute Charleston West Virginia 25309 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02683408, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 17, 2017 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02683408 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →